Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume - Still a Buy?

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) shares saw unusually-strong trading volume on Tuesday . Approximately 126,701 shares traded hands during trading, an increase of 61% from the previous session's volume of 78,834 shares.The stock last traded at $17.16 and had previously closed at $17.12.

Sysmex Stock Performance

The stock has a market cap of $10.83 billion, a price-to-earnings ratio of 30.71 and a beta of 1.14. The stock's 50 day moving average is $17.45 and its two-hundred day moving average is $18.21. The company has a current ratio of 2.97, a quick ratio of 2.30 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings data on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). The firm had revenue of $958.89 million during the quarter, compared to analyst estimates of $991.22 million. Sysmex had a net margin of 10.56% and a return on equity of 11.81%. Analysts anticipate that Sysmex Corporation ADR will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.